Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Stephen Crosier

Newcastle AuthorsTitleYearFull text
Dr Ed Schwalbe
Dr Janet Lindsey
Dr Marina Danilenko
Dr Rebecca Hill
Dr Stephen Crosier
et al.
Molecular and clinical heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcomes: A multicenter cohort study2025
Magretta Adiamah
Beth Poole
Dr Janet Lindsey
Dr Rebecca Hill
Dr Helen Blair
et al.
MYC-dependent upregulation of the de novo serine and glycine synthesis pathway is a targetable metabolic vulnerability in group 3 medulloblastoma2025
Dr Marion Mateos
Dr Daniel Williamson
Dr Marina Danilenko
Dr Jack Goddard
Dr Stephen Crosier
et al.
MDB-64. Novel transcripts associate with survival in childhood medulloblastoma.2024
Dr Florence Burté
Magretta Adiamah
Dr Fatma Scerif
Dr Debbie Hicks
Dr Ed Schwalbe
et al.
Metabolite profiles of medulloblastoma for rapid and non-invasive detection of molecular disease groups2024
Dr Jack Goddard
Jemma Castle
Emily Southworth
Anya Fletcher
Dr Stephen Crosier
et al.
Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification2023
Dr Stacey Richardson
Dr Rebecca Hill
Dr Christopher Kui
Dr Janet Lindsey
Dr Yura Grabovska
et al.
Emergence and maintenance of actionable genetic drivers at medulloblastoma relapse2022
Dr Daniel Williamson
Dr Ed Schwalbe
Dr Debbie Hicks
Dr Janet Lindsey
Dr Stephen Crosier
et al.
Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar development2022
Dr Marina Danilenko
Dr Claire Keeling
Dr Stephen Crosier
Dr Martina Finetti
Dr Daniel Williamson
et al.
Single-cell DNA sequencing identifies risk-associated clonal complexity and evolutionary trajectories in childhood medulloblastoma development2022
Dr Stephen Crosier
Dr Debbie Hicks
Dr Ed Schwalbe
Dr Daniel Williamson
Amanda Smith
et al.
Advanced molecular pathology for rare tumours: A national feasibility study and model for centralised medulloblastoma diagnostics2021
Dr Debbie Hicks
Dr Reza Rafiee
Dr Ed Schwalbe
Dr Christopher Howell
Dr Janet Lindsey
et al.
The molecular landscape and associated clinical experience in infant medulloblastoma: prognostic significance of second-generation subtypes2021
Dr Stephen Crosier
Professor Simon Bailey
Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes2020
Dr Yura Grabovska
Dr Stephen Crosier
Dr Martina Finetti
Dr Ed Schwalbe
Dr Rebecca Hill
et al.
Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunity2020
Dr Rebecca Hill
Dr Stacey Richardson
Dr Ed Schwalbe
Dr Debbie Hicks
Dr Janet Lindsey
et al.
Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study2020
Dr Ed Schwalbe
Dr Debbie Hicks
Dr Reza Rafiee
Dr Matthew Bashton
Dr Amir Enshaei
et al.
Minimal methylation classifier (MIMIC): A novel method for derivation and rapid diagnostic detection of disease-associated DNA methylation signatures2017
Dr Ed Schwalbe
Dr Janet Lindsey
Dr Sirintra Nakjang
Dr Stephen Crosier
Amanda Smith
et al.
Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study2017
1234